Notification Detail
Draft Commission Regulation amending the Appendices to Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards CMR substances (3 pages + Annex 4 pages, in English).
Reference: G/TBT/N/EU/496
Date of arrival: 2017 July 28 - Final date for comments:
2017 September 26
Description
This draft Commission Regulation proposes to include within the scope of entries 28 to 30 of Annex XVII to Regulation (EC) No 1907/2006 the substances listed below, with the effect of restricting their placing on the market or use for supply to the general public as substances on their own, as constituents of other substances or in mixtures and to impose the requirement to mark packaging with the label "restricted to professional users". This is consequent on the recent classification of these substances as CMR category 1A or 1B under Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, as amended by Commission Regulation (EU) 2017/776. The substances are: 2,3-epoxypropyl methacrylate; glycidyl methacrylate; cadmium carbonate; cadmium hydroxide; cadmium dihydroxide; cadmium nitrate; cadmium dinitrate; Anthraquinone; N,N'-methylenedimorpholine; N,N'-methylenebismorpholine; [formaldehyde released from N,N'-methylenebismorpholine][MBM]; reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2); [formaldehyde released from 3,3'-methylenebis[5-methyloxazolidine]; formaldehyde released from oxazolidin] [MBO]; reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1); [formaldehyde released from ±,±,±-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol] [HPT]; methylhydrazine; cadmium carbonate; cadmium hydroxide; cadmium dihydroxide; cadmium nitrate; cadmium dinitrate; 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one; 2,3-epoxypropyl methacrylate; glycidyl methacrylate; cyproconazole (ISO); (2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; dibutyltin dilaurate; dibutyl[bis(dodecanoyloxy)]stannane; nonadecafluorodecanoic acid [1]; ammonium nonadecafluorodecanoate [2]; sodium nonadecafluorodecanoate [3]; triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol;±-tert-butyl-²-(4-chlorophenoxy)-1H-1,2,4-triazole-1-ethanol; quinolin-8-ol; 8-hydroxyquinoline; thiacloprid (ISO); (Z)-3-(6-chloro-3-pyridylmethyl)-1,3-thiazolidin-2-ylidenecyanamide; {(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide; carbetamide (ISO); (R)-1-(ethylcarbamoyl)ethyl carbanilate; (2R)-1-(ethylamino)-1-oxopropan-2-yl phenylcarbamate.The substance formaldehyde ...%, which was classified as a carcinogen category 1B by Commission Regulation (EU) No 605/2014, is also now included within the scope of entries 28 to 30 of Annex XVII to REACH.Objectives
Prevention of Deceptive Practices & Cons. Protect.Protection of Human Health or Safety
Fields of Activity
CHEMICAL TECHNOLOGY
Disclaimer: Please note that the information published is not necessarily comprehensive.
In particular, documents of notifications dated before 1 January 2014, and
comments and answers received or sent on TBT notifications before 1 January 2018 are not
publicly available due to data protection requirements. Some comments and answers received or sent after 1 January 2018 may be unavailable also for data protection reasons.